Increased susceptibility to pulmonary pseudomonas infection in SPLUNC1 knockout mice

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4259-4268

  Liu, Yanyan ^a,b   Di, Marissa E ^a   Chu, Hong Wei ^c   Liu, Xinyu ^a   Wang, Ling ^b   Wenzel, Sally ^d   Di, Y Peter ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c DEPARTMENT OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SECRETORY PROTEIN; SHORT PALATE LUNG AND NASAL EPITHELIUM CLONE 1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL LOAD; BACTERIAL MEMBRANE; CONTROLLED STUDY; INFECTION SENSITIVITY; KNOCKOUT MOUSE; LUNG INFECTION; LUNG INJURY; MEMBRANE FORMATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS INFECTION; SURVIVAL RATE; WILD TYPE;

ANIMALS; BACTERIAL LOAD; BIOFILMS; CHEMOKINE CCL20; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CYTOKINES; GLYCOPROTEINS; LUNG; MICE; MICE, KNOCKOUT; PHOSPHOPROTEINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY MUCOSA; RESPIRATORY TRACT INFECTIONS; SURVIVAL RATE;

EID: 84885459118     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202340     Document Type: Article

References (49)

1. Parker, D., and A. Prince. 2011. Innate immunity in the respiratory epithelium. Am. J. Respir. Cell Mol. Biol. 45: 189-201.
2. Di, Y. P. 2011. Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria. Biochem. Soc. Trans. 39: 1051-1055.
3. Kim, K. C. 2012. Role of epithelial mucins during airway infection. Pulm. Pharmacol. Ther. 25: 415-419.
4. Sayeed, S., L. Nistico, C. St Croix, and Y. P. Di. 2013. Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect. Immun. 81: 285-291.
5. Di, Y. P., R. Harper, Y. Zhao, N. Pahlavan, W. Finkbeiner, and R. Wu. 2003. Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts. J. Biol. Chem. 278: 1165-1173.
6. Campos, M. A., A. R. Abreu, M. C. Nlend, M. A. Cobas, G. E. Conner, and P. L. Whitney. 2004. Purification and characterization of PLUNC from human tracheobronchial secretions. Am. J. Respir. Cell Mol. Biol. 30: 184-192.
7. Lukinskiene, L., Y. Liu, S. D. Reynolds, C. Steele, B. R. Stripp, G. D. Leikauf, J. K. Kolls, and Y. P. Di. 2011. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J. Immunol. 187: 382-390.
8. Gakhar, L., J. A. Bartlett, J. Penterman, D. Mizrachi, P. K. Singh, R. K. Mallampalli, S. Ramaswamy, and P. B. McCray, Jr. 2010. PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS ONE 5: e9098.
9. Chu, H. W., J. Thaikoottathil, J. G. Rino, G. Zhang, Q. Wu, T. Moss, Y. Refaeli, R. Bowler, S. E. Wenzel, Z. Chen, et al. 2007. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. J. Immunol. 179: 3995-4002.
10. Gally, F., Y. P. Di, S. K. Smith, M. N. Minor, Y. Liu, D. L. Bratton, S. C. Frasch, N. M. Michels, S. R. Case, and H. W. Chu. 2011. SPLUNC1 promotes lung innate defense against Mycoplasma pneumoniae infection in mice. Am. J. Pathol. 178: 2159-2167.
11. Di, Y. P., A. V. Tkach, N. Yanamala, S. Stanley, S. Gao, M. R. Shurin, E. R. Kisin, V. E. Kagan, and A. Shvedova. 2013. Dual acute pro-inflammatory and anti-fibrotic pulmonary effects of SPLUNC1 after exposure to carbon nanotubes. Am. J. Respir. Cell Mol. Biol. PMID: 23721177.
12. Garcia-Caballero, A., J. E. Rasmussen, E. Gaillard, M. J. Watson, J. C. Olsen, S. H. Donaldson, M. J. Stutts, and R. Tarran. 2009. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc. Natl. Acad. Sci. USA 106: 11412-11417.
13. Van Eldere, J. 2003. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J. Antimicrob. Chemother. 51: 347-352.
14. Liu, Y., J. A. Bartlett, M. E. Di, J. M. Bomberger, Y. R. Chan, L. Gakhar, R. K. Mallampalli, P. B. McCray, Jr., and Y. P. Di. 2013. SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection. Am. J. Pathol. 182: 1519-1531.
15. O'Toole, G. A., and R. Kolter. 1998. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30: 295-304.
16. Anderson, G. G., S. Moreau-Marquis, B. A. Stanton, and G. A. O'Toole. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 76: 1423-1433.
17. Harrod, K. S., A. D. Mounday, B. R. Stripp, and J. A. Whitsett. 1998. Clara cell secretory protein decreases lung inflammation after acute virus infection. Am. J. Physiol. 275: L924-L930.
18. Hoffmann, J. A., F. C. Kafatos, C. A. Janeway, and R. A. Ezekowitz. 1999. Phylogenetic perspectives in innate immunity. Science 284: 1313-1318.
19. Iida, N., and G. R. Grotendorst. 1990. Cloning and sequencing of a new gro transcript from activated human monocytes: expression in leukocytes and wound tissue. Mol. Cell. Biol. 10: 5596-5599.
20. Becker, S., J. Quay, H. S. Koren, and J. S. Haskill. 1994. Constitutive and stimulated MCP-1, GROa, b, and g expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 266: L278-L286.
21. Schumacher, C., I. Clark-Lewis, M. Baggiolini, and B. Moser. 1992. High-And low-Affinity binding of GROa and neutrophil-Activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc. Natl. Acad. Sci. USA 89: 10542-10546.
22. Pelus, L. M., and S. Fukuda. 2006. Peripheral blood stem cell mobilization: the CXCR2 ligand GROb rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp. Hematol. 34: 1010-1020.
23. Wolpe, S. D., B. Sherry, D. Juers, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86: 612-616.
24. Walz, A., R. Burgener, B. Car, M. Baggiolini, S. L. Kunkel, and R. M. Strieter. 1991. Structure and neutrophil-Activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J. Exp. Med. 174: 1355-1362.
25. Moalli, F., M. Paroni, T. Véliz Rodriguez, F. Riva, N. Polentarutti, B. Bottazzi, S. Valentino, S. Mantero, M. Nebuloni, A. Mantovani, et al. 2011. The therapeutic potential of the humoral pattern recognition molecule PTX3 in chronic lung infection caused by Pseudomonas aeruginosa. J. Immunol. 186: 5425-5434.
26. Reiniger, N., J. K. Ichikawa, and G. B. Pier. 2005. Influence of cystic fibrosis transmembrane conductance regulator on gene expression in response to Pseudomonas aeruginosa infection of human bronchial epithelial cells. Infect. Immun. 73: 6822-6830.
27. Carrigan, S. O., R. Junkins, Y. J. Yang, A. Macneil, C. Richardson, B. Johnston, and T. J. Lin. 2010. IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice. J. Immunol. 185: 3602-3609.
28. Liu, Y., and Y. P. Di. 2012. Effects of second hand smoke on airway secretion and mucociliary clearance. Front Physiol 3: 342.
29. Knowles, M. R., and R. C. Boucher. 2002. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109: 571-577.
30. Tarran, R. 2004. Regulation of airway surface liquid volume and mucus transport by active ion transport. Proc. Am. Thorac. Soc. 1: 42-46.
31. Thornton, D. J., K. Rousseau, and M. A. McGuckin. 2008. Structure and function of the polymeric mucins in airways mucus. Annu. Rev. Physiol. 70: 459-486.
32. Singh, G., S. L. Katyal, W. E. Brown, A. L. Kennedy, U. Singh, and M. L. Wong-Chong. 1990. Clara cell 10 kDa protein (CC10): comparison of structure and function to uteroglobin. Biochim. Biophys. Acta 1039: 348-355.
33. Harrod, K. S., and R. J. Jaramillo. 2002. Pseudomonas aeruginosa and tumor necrosis factor-A attenuate Clara cell secretory protein promoter function. Am. J. Respir. Cell Mol. Biol. 26: 216-223.
34. Hayashida, S., K. S. Harrod, and J. A. Whitsett. 2000. Regulation and function of CCSP during pulmonary Pseudomonas aeruginosa infection in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L452-L459.
35. Snyder, J. C., S. D. Reynolds, J. W. Hollingsworth, Z. W. Li, N. Kaminski, and B. R. Stripp. 2010. Clara cells attenuate the inflammatory response through regulation of macrophage behavior. Am. J. Respir. Cell Mol. Biol. 42: 161-171.
36. Hackett, B. P., S. L. Brody, M. Liang, I. D. Zeitz, L. A. Bruns, and J. D. Gitlin. 1995. Primary structure of hepatocyte nuclear factor/forkhead homologue 4 and characterization of gene expression in the developing respiratory and reproductive epithelium. Proc. Natl. Acad. Sci. USA 92: 4249-4253.
37. Clevidence, D. E., D. G. Overdier, R. S. Peterson, A. Porcella, H. Ye, K. E. Paulson, and R. H. Costa. 1994. Members of the HNF-3/forkhead family of transcription factors exhibit distinct cellular expression patterns in lung and regulate the surfactant protein B promoter. Dev. Biol. 166: 195-209.
38. Chen, J., H. J. Knowles, J. L. Hebert, and B. P. Hackett. 1998. Mutation of the mouse hepatocyte nuclear factor/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry. J. Clin. Invest. 102: 1077-1082.
39. Plopper, C. G., S. J. Nishio, J. L. Alley, P. Kass, and D. M. Hyde. 1992. The role of the nonciliated bronchiolar epithelial (Clara) cell as the progenitor cell during bronchiolar epithelial differentiation in the perinatal rabbit lung. Am. J. Respir. Cell Mol. Biol. 7: 606-613.
40. Perl, A. K., S. E. Wert, D. E. Loudy, Z. Shan, P. A. Blair, and J. A. Whitsett. 2005. Conditional recombination reveals distinct subsets of epithelial cells in trachea, bronchi, and alveoli. Am. J. Respir. Cell Mol. Biol. 33: 455-462.
41. Gudmundsson, G. H., B. Agerberth, J. Odeberg, T. Bergman, B. Olsson, and R. Salcedo. 1996. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur. J. Biochem. 238: 325-332.
42. Byfield, F. J., M. Kowalski, K. Cruz, K. Leszczyńska, A. Namiot, P. B. Savage, R. Bucki, and P. A. Janmey. 2011. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa. J. Immunol. 187: 6402-6409.
43. Valenti, P., F. Berlutti, M. P. Conte, C. Longhi, and L. Seganti. 2004. Lactoferrin functions: current status and perspectives. J. Clin. Gastroenterol. 38(6, Suppl.): S127-S129.
44. Singh, P. K., M. R. Parsek, E. P. Greenberg, and M. J. Welsh. 2002. A component of innate immunity prevents bacterial biofilm development. Nature 417: 552-555.
45. Kamiya, H., T. Ehara, and T. Matsumoto. 2012. Inhibitory effects of lactoferrin on biofilm formation in clinical isolates of Pseudomonas aeruginosa. J. Infect. Chemother. 18: 47-52.
46. Cole, A. M., H. I. Liao, O. Stuchlik, J. Tilan, J. Pohl, and T. Ganz. 2002. Cationic polypeptides are required for antibacterial activity of human airway fluid. J. Immunol. 169: 6985-6991.
47. Cole, A. M., D. R. Thapa, V. Gabayan, H. I. Liao, L. Liu, and T. Ganz. 2005. Decreased clearance of Pseudomonas aeruginosa from airways of mice deficient in lysozyme M. J. Leukoc. Biol. 78: 1081-1085.
48. Dajani, R., Y. Zhang, P. J. Taft, S. M. Travis, T. D. Starner, A. Olsen, J. Zabner, M. J. Welsh, and J. F. Engelhardt. 2005. Lysozyme secretion by submucosal glands protects the airway from bacterial infection. Am. J. Respir. Cell Mol. Biol. 32: 548-552.
49. Travis, S. M., B. A. Conway, J. Zabner, J. J. Smith, N. N. Anderson, P. K. Singh, E. P. Greenberg, and M. J. Welsh. 1999. Activity of abundant antimicrobials of the human airway. Am. J. Respir. Cell Mol. Biol. 20: 872-879.